Amber Dahlin
Impact in
- Physiology top 5%
- Asthma and respiratory diseases
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways
Papers in
- Physiology 25
- Asthma and respiratory diseases 24
-
- Metabolomics and Mass Spectrometry Studies 4
- Receptor Mechanisms and Signaling 3
- Co-authors
- Kelan G. Tantisira (19 shared papers)Ann Chen Wu (18 shared papers)Jessica Lasky‐Su (18 shared papers)Ingegerd Hellström (3 shared papers)Martha Hayden-Ledbetter (2 shared papers)Jeffrey A. Ledbetter (2 shared papers)Karl Erik Hellström (2 shared papers)Michael J. McGeachie (16 shared papers)
- Journals
- Clinical & Experimental Allergy (3 papers)Journal of Allergy and Clinical Immunology (2 papers)Journal of Personalized Medicine (2 papers)The Pharmacogenomics Journal (2 papers)PLoS ONE (2 papers)
- Partner nations
- United StatesJapanCosta Rica
In The Last Decade
Amber Dahlin
40 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 107
- Physiology 482
- Immunology 387
- Immunology and Allergy 63
- Oncology 273
- Pediatrics, Perinatology and Child Health 189
Countries citing papers authored by Amber Dahlin
This map shows the geographic impact of Amber Dahlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber Dahlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber Dahlin more than expected).
Fields of papers citing papers by Amber Dahlin
This network shows the impact of papers produced by Amber Dahlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber Dahlin. The network helps show where Amber Dahlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Amber Dahlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 134 | |
| 2 | 2012 | 130 | |
| 3 | 2002 | 123 | |
| 4 | 2016 | 122 | |
| 5 | 2002 | 103 | |
| 6 | 2007 | 99 | |
| 7 | 2004 | 82 | |
| 8 | 2009 | 79 | |
| 9 | 2015 | 65 | |
| 10 | 2014 | 60 | |
| 11 | 2012 | 45 | |
| 12 | 2016 | 43 | |
| 13 | 2017 | 39 | |
| 14 | 2012 | 39 | |
| 15 | 2012 | 37 | |
| 16 | 2018 | 35 | |
| 17 | 2015 | 31 | |
| 18 | 2015 | 27 | |
| 19 | 2014 | 23 | |
| 20 | 2012 | 23 |
About Amber Dahlin
Amber Dahlin is a scholar working on Physiology, Molecular Biology, Immunology, Oncology and Pulmonary and Respiratory Medicine, having authored 41 papers that have together received 1.6k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (24 papers), IL-33, ST2, and ILC Pathways (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Receptor Mechanisms and Signaling (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Physiology (482 citations), Immunology (387 citations), Immunology and Allergy (63 citations), Oncology (273 citations) and Pediatrics, Perinatology and Child Health (189 citations). Amber Dahlin has collaborated with scholars based in United States, Japan and Costa Rica. Frequent co-authors include Kelan G. Tantisira, Ann Chen Wu, Jessica Lasky‐Su, Ingegerd Hellström, Martha Hayden-Ledbetter, Jeffrey A. Ledbetter, Karl Erik Hellström, Michael J. McGeachie, Scott T. Weiss and Joanne E. Sordillo. Their work appears in journals such as Clinical & Experimental Allergy, Journal of Allergy and Clinical Immunology, Journal of Personalized Medicine, The Pharmacogenomics Journal and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.